Subtype
Intermediate Soft Tissue Neoplasm
CI-CAN-00001021Explore in graph →
Non-malignant32 active trials42 evidence items
- NCIt
- C7653
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001021Explore in graph →
Clinical trials
136 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05877066 | Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture(GRASP-DC) | terminated | — | 130 | Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY | 1 | Apr 16, 2024 | clinicaltrials |
| NCT02110069 | A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors | terminated | Phase 2 | 4 | Boston Children's HospitalOTHER | 1 | Sep 21, 2023 |
| clinicaltrials |
| NCT02465528 | Ceritinib Rare Indications Study in ALK+ Tumors | terminated | Phase 2 | 22 | Novartis PharmaceuticalsINDUSTRY | 8 | Dec 27, 2019 | clinicaltrials |
| NCT02374931 | 18F-FES PET/CT in Imaging Patients With Desmoid Tumors | terminated | Early Phase 1 | 3 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Oct 3, 2019 | clinicaltrials |
| NCT01059656 | Phase II Pazopanib Study in Advanced Dermatofibrosarcomas(DFSP-PAZO) | terminated | Phase 2 | 23 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jul 1, 2016 | clinicaltrials |
Data updated 22 days agoSource updated Apr 16, 2024source: clinicaltrials